Stay updated with breaking news from Aexon Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ZURICH, SWITZERLAND / ACCESSWIRE / December 29, 2023 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company, focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system...
In a letter to shareholders, the CEO of NLS Pharmaceutics Ltd recapped the company’s progress and pitfalls for 2023.
Zürich, Switzerland, December 29, 2023 - NLS Pharmaceutics Ltd. , a Swiss clinical-stage biopharmaceutical company, focused on the discovery and development of innovative therapies for...
UNAUDITED INTERIM CONDENSED FINANCIAL STATEMENTS Page ...
NLS Pharmaceutics entered into an exclusive option agreement with Aexon Labs to develop its dual orexin receptor agonists platform.